In the last 12 months, insiders at Emmaus Life Sciences, Inc. ($EMMA) filed 18 transactions with the SEC: 11 open-market purchases totaling $30,779 and 0 sales totaling $0. Net insider sentiment: net buying.
Emmaus Life Sciences, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- LEE WILLIS C (COO) — 6 transactions totaling $15,285
- LEE WILLIS C (Co-President & COO) — 5 transactions totaling $14,694
- Lim Seah H. (Not found) — 1 transaction totaling $800
- ZEN Wei Peu (Director) — 1 transaction totaling $0
- Sekulich George (Co-President & CCO) — 1 transaction totaling $0
View all SEC Filings for Emmaus Life Sciences, Inc. (EMMA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 16, 2024 | Lim Seah H. | Not found | P | Common stock, $0.001 par value | 20000 | $0.04 | 4,606,626.0000 | 0 | 0.44% | 0.00% |
| Feb. 26, 2024 | LEE WILLIS C | Co-President & COO | P | Common stock, $0.001 par value | 13200 | $0.12 | 693,718.0000 | 0 | 1.94% | 0.00% |
| Feb. 27, 2024 | LEE WILLIS C | Co-President & COO | P | Common stock, $0.001 par value | 10000 | $0.13 | 703,718.0000 | 0 | 1.44% | 0.00% |
| Feb. 28, 2024 | LEE WILLIS C | Co-President & COO | P | Common stock, $0.001 par value | 15000 | $0.12 | 718,718.0000 | 0 | 2.13% | 0.00% |
| Feb. 29, 2024 | LEE WILLIS C | Co-President & COO | P | Common stock, $0.001 par value | 77000 | $0.13 | 795,718.0000 | 0 | 10.71% | 0.00% |
| Feb. 1, 2024 | Zwicker Ian Harvey | Director | A | Options | 100000 | $0.15 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | ZEN Wei Peu | Director | A | Options | 100000 | $0.15 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Lim Seah H. | Director | A | Options | 100000 | $0.15 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Stark Charles William | CSO & EVP Clinical Development | A | Options | 200000 | $0.15 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Sekulich George | Co-President & CCO | A | Options | 200000 | $0.15 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | NAGASAKI YASUSHI | CFO | A | Options | 200000 | $0.15 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | LEE WILLIS C | Co-President & COO | A | Options | 200000 | $0.15 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 25, 2023 | LEE WILLIS C | COO | P | Common stock, $0.001 par value | 6500 | $0.21 | 673,418.0000 | 0 | 0.97% | 0.00% |
| Aug. 31, 2023 | LEE WILLIS C | COO | P | Common stock, $0.001 par value | 6000 | $0.15 | 679,418.0000 | 0 | 0.89% | 0.00% |
| Nov. 14, 2023 | LEE WILLIS C | COO | P | Common stock, $0.001 par value | 1100 | $0.12 | 680,518.0000 | 0 | 0.16% | 0.00% |
| Nov. 28, 2023 | LEE WILLIS C | COO | P | Common stock, $0.001 par value | 12000 | $0.12 | 585,118.0000 | 0 | 2.09% | 0.00% |
| Nov. 29, 2023 | LEE WILLIS C | COO | P | Common stock, $0.001 par value | 36000 | $0.12 | 621,118.0000 | 0 | 6.15% | 0.00% |
| Nov. 30, 2023 | LEE WILLIS C | COO | P | Common stock, $0.001 par value | 59400 | $0.12 | 680,518.0000 | 0 | 9.56% | 0.00% |